Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Louis McIntyre

Orthopaedic Surgery Clemmons, NC Medical Doctor

NPI 1699789347 CMS profile 76496

7210 Village Medical Cir Ste 110, Clemmons, NC 27012

Open in the dashboard

General payments

$418,880

124 records reported · program years 2019–2025

Research payments

$3,021

Paid to them · 4 records reported · program years 2019–2025

Ownership & investment interest

$13,888

1 holding reported · through program year 2025

Research they led as principal investigator

$82,953 paid to institutions, not to them · program year 2019

Through program year 2025, Louis McIntyre of Clemmons, NC is reported in the CMS Open Payments database as having received $418,880 across 124 general payments and $3,021 in research payments paid to them. Separately, studies naming them as principal investigator received $82,953 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $13,888 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $69,987 9
2024 General $51,964 5
2023 General $207,819 16
2022 General $45,853 53
2021 General $15,857 12
2021 Research $1,250 1
2020 General $3,855 8
2020 Research $250 1
2019 General $23,545 21
2019 Research $1,521 2
2022 Ownership $13,888 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Louis McIntyre
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Louis McIntyre were reported at $69,987. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Louis McIntyre Orthopaedic Surgery median Middle half National median
2019 $23,545 $644 $140–$2,844 $163
2020 $3,855 $312 $75–$1,860 $114
2021 $15,857 $520 $117–$2,495 $132
2022 $45,853 $598 $128–$2,731 $149
2023 $207,819 $461 $128–$2,264 $160
2024 $51,964 $497 $134–$2,475 $164
2025 $69,987 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $322,575 23 payments
  2. Smith+Nephew, Inc. $60,645 64 payments
  3. Sanofi-Aventis U.S. LLC $21,230 7 payments
  4. Bioventus LLC $4,399 3 payments
  5. Maruho Medical Inc. $3,788 3 payments
  6. Embody, Inc. $2,989 4 payments
  7. Flexion Therapeutics, Inc. $1,894 7 payments
  8. Tosoh Bioscience, Inc. $491 1 payment
  9. Arthrex, Inc. $290 5 payments
  10. Stryker Corporation $163 1 payment
  11. Other $416 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Acquisitions $271,234 4 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $52,122 21 payments
  3. Royalty or License $47,105 11 payments
  4. Consulting Fee $34,752 19 payments
  5. Travel and Lodging $9,943 35 payments
  6. Food and Beverage $3,182 32 payments
  7. Gift $491 1 payment
  8. Honoraria $50 1 payment
Products named General payments · program years 2019–2025
  1. Tapestry $241,227 15 payments
  2. Bioinductive Implant with Arthroscopic Delivery System - Medium $33,267 27 payments
  3. HEALICOIL Sports Med Shoulder $17,415 8 payments
  4. Bone Anchors with Arthroscopic Delivery System $16,162 24 payments
  5. HEALICOIL Sports Med Shoulder $15,440 8 payments
  6. NO PRODUCT DISCUSSED $11,429 1 payment
  7. SYNVISC $8,679 4 payments
  8. HEALICOIL REGENESORB $5,250 2 payments
  9. REGENETEN $4,944 6 payments
  10. NOVOSTITCH $4,857 7 payments
  11. Other $54,311 43 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Smith+Nephew, Inc. $1,771 3 payments
  2. Sanofi-Aventis U.S. LLC $1,250 1 payment

Billing to Medicare

Part B · data year 2024 · 17 billing codes

Paid by Medicare

$8,295

Of which drugs: $1,204

Medicare patients

51

Average age 75

Services billed

267

31 women, 20 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 33%
Ischemic heart disease 29%
Chronic kidney disease 29%
Depression 29%
Osteoporosis 25%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 17 136 $93

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

128 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record